What dose of aspirin should be used in the initial treatment of Kawasaki disease?

Arch Dis Child. 2017 Dec;102(12):1180-1182. doi: 10.1136/archdischild-2017-313538. Epub 2017 Oct 24.

Authors

Luke Guo Yang Ho^{1

2}, Nigel Curtis²

Affiliations

¹ Monash School of Medicine, Monash University, Clayton, Victoria, Australia.
² Department of Paediatrics, The University of Melbourne and Murdoch Children's Research Institute, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

PMID: 29066520
DOI: 10.1136/archdischild-2017-313538

No abstract available

Keywords: evidence based medicine; infectious diseases.

Publication types

Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Aspirin / administration & dosage*
Aspirin / adverse effects
Child
Coronary Artery Disease / etiology
Coronary Artery Disease / prevention & control*
Humans
Mucocutaneous Lymph Node Syndrome / complications
Mucocutaneous Lymph Node Syndrome / drug therapy*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin